Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Symphogen A/S
DescriptionMixture of 2 humanized IgG1 mAbs that bind to non-overlapping epitopes in the extracellular domain of c-Met receptor tyrosine kinase (c-MET; MET; HGFR; c-Met proto-oncogene)
Molecular Target c-Met receptor tyrosine kinase (c-MET) (MET) (HGFR) (c-Met proto-oncogene)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today